Medicus Pharma Ltd.
Viktoriia Slepeniuk currently serves as Vice President of Investor Relations at Medicus Pharma Ltd. and Vice President of Investor Relations and Communications at RBx Capital LP, both positions held since September and August 2023, respectively. In addition, Viktoriia has been a Corporate Affairs Manager and Vice President at Parkway Clinical Laboratories, Inc. since March 2019. Previously, Viktoriia worked as a Capital Markets Associate at FSD Pharma Inc. from September 2019 to May 2021 and held various roles at T3 Trading Group, LLC between August 2012 and August 2014. Viktoriia holds a Bachelor's degree in International Relations and Affairs from Chernivci National 'Juriy Fedkovyc' University.
This person is not in any teams
This person is not in any offices
Medicus Pharma Ltd.
Medicus Pharma Ltd. (TSXV:MDCX) is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets. Through our diverse experience and extensive industry network, we are building Medicus into a leading pharmaceutical company, committed to deliver better treatment outcomes and alleviate pain and suffering. Utilizing a thesis driven collaborative process, we identify, acquire and advance relatively de-risked clinical stage assets through clinical development and commercialization. We look into opportunities where an unmet need exists for improved patient safety and efficacy. Medicus is opportunisticly exploring to expand its drug development pipeline through qualified and accretive acquisitions and partnerships. Our portfolio of companies include Skinject, Inc.